ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype.

Michelle ShenShiqin LiuAngus TolandEn-Chi HsuAlifiani B HartonoBusola R AlabiMerve AslanHolly M NguyenConner J SessionsRosalie NolleyChanjuan ShiJiaoti HuangJames D BrooksEva CoreyTanya Stoyanova

Published in: British journal of cancer (2023)

ACAA2 expression is elevated in aggressive SCNCs such as NEPC and SCLC, suggesting it is a potential molecular indicator for SCNCs.

Keyphrases

poor prognosis
long non coding rna
risk assessment
human health
young adults
climate change